tetano
Editor, Senior Moderator
Eur J Case Rep Intern Med
. 2021 Dec 21;8(12):002854.
doi: 10.12890/2021_002854. eCollection 2021.
Unexpected Pulmonary Embolism Late After Recovery from Mild COVID-19?
Doranna De Pace[SUP] 1 [/SUP], Sara Ariotti[SUP] 1 [/SUP], Simone Persampieri[SUP] 1 [/SUP], Giuseppe Patti[SUP] 2 [/SUP], Alessandro Lupi[SUP] 1 [/SUP]
Affiliations
Abstract
SARS-CoV-2 infection is associated with an increased risk of venous thromboembolism (VTE), which is common during active illness but unusual in milder cases and after healing. We describe a case of bilateral acute pulmonary embolism occurring 3 months after recovery from a paucisymptomatic SARS-CoV-2 infection. The only VTE risk factor demonstrable was a history of previous SARS-CoV-2 infection, with laboratory signs of residual low-grade inflammation. Clinicians should be aware of VTE as a potential cause of sudden dyspnoea after COVID-19 resolution, especially in the presence of persistent systemic inflammation.
Learning points: Venous thromboembolism may occur after COVID-19, even in milder SARS-CoV-2 infections and late after coronavirus clearance.Laboratory signs of systemic inflammation are clues for suspecting venous thromboembolism as a cause of sudden dyspnoea in patients with low risk scores for pulmonary embolism but with previous COVID-19 infection.
Keywords: COVID-19; SARS-CoV-2; direct oral anticoagulants; inflammation; pulmonary embolism; thrombosis.
. 2021 Dec 21;8(12):002854.
doi: 10.12890/2021_002854. eCollection 2021.
Unexpected Pulmonary Embolism Late After Recovery from Mild COVID-19?
Doranna De Pace[SUP] 1 [/SUP], Sara Ariotti[SUP] 1 [/SUP], Simone Persampieri[SUP] 1 [/SUP], Giuseppe Patti[SUP] 2 [/SUP], Alessandro Lupi[SUP] 1 [/SUP]
Affiliations
- PMID: 35059331
- PMCID: PMC8765695
- DOI: 10.12890/2021_002854
Abstract
SARS-CoV-2 infection is associated with an increased risk of venous thromboembolism (VTE), which is common during active illness but unusual in milder cases and after healing. We describe a case of bilateral acute pulmonary embolism occurring 3 months after recovery from a paucisymptomatic SARS-CoV-2 infection. The only VTE risk factor demonstrable was a history of previous SARS-CoV-2 infection, with laboratory signs of residual low-grade inflammation. Clinicians should be aware of VTE as a potential cause of sudden dyspnoea after COVID-19 resolution, especially in the presence of persistent systemic inflammation.
Learning points: Venous thromboembolism may occur after COVID-19, even in milder SARS-CoV-2 infections and late after coronavirus clearance.Laboratory signs of systemic inflammation are clues for suspecting venous thromboembolism as a cause of sudden dyspnoea in patients with low risk scores for pulmonary embolism but with previous COVID-19 infection.
Keywords: COVID-19; SARS-CoV-2; direct oral anticoagulants; inflammation; pulmonary embolism; thrombosis.